EXPRESSION OF CYTOCHROME-P450-3A5 IN ESCHERICHIA-COLI - EFFECTS OF 5' MODIFICATION, PURIFICATION, SPECTRAL CHARACTERIZATION, RECONSTITUTION CONDITIONS, AND CATALYTIC ACTIVITIES

被引:141
作者
GILLAM, EMJ
GUO, ZY
UENG, YF
YAMAZAKI, H
COCK, I
REILLY, PEB
HOOPER, WD
GUENGERICH, FP
机构
[1] UNIV QUEENSLAND,DEPT PHYSIOL & PHARMACOL,ST LUCIA,QLD 4072,AUSTRALIA
[2] UNIV QUEENSLAND,DEPT BIOCHEM,ST LUCIA,QLD 4072,AUSTRALIA
[3] UNIV QUEENSLAND,DEPT MED,ST LUCIA,QLD 4072,AUSTRALIA
[4] VANDERBILT UNIV,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232
[5] VANDERBILT UNIV,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37232
关键词
P450; 3A5; ESCHERICHIA COLI; HETEROLOGOUS EXPRESSION; ENZYME PURIFICATION; NIFEDIPINE;
D O I
10.1006/abbi.1995.1177
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 (P450) 3A5 is a human enzyme with 85% amino acid sequence identity to the more predominantly expressed P450 3A4 and has been reported to have overlapping catalytic specificity. The 5'-terminus of a P450 3A5 cDNA was modified for optimal expression in Escherichia coli using the vector pCW, by aligning the MALLLAVFL N-terminal sequence of recombinant bovine P450 17A (H. J. Barnes, M. P. Arlotto, and M. R. Waterman, (1991) Proc. Natl. Acad. Sci. USA 88, 5597-5601) to the 3A5 cDNA. Two constructs were made, differing by their identity with the modified 3A4 N-terminal sequence (E. M. J. Gillam, T. Baba, B-R. Rim, S. Ohmori, and F. P. Guengerich, (1993) Arch. Biochem. Biophys. 305, 123-131). The first modified sequence (3A5#1) was identical to recombinant P450 3A4 up to codon 15, the 3A5 sequence being introduced thereafter. In the other (3A5#2), the successful 3A4 N-terminal nucleotide sequence was attached to codon 30. The yield was greater than fourfold higher in the first construct [up to 260 nmol (liter culture)(-1)]. The recombinant P450 3A5 (construct 1) was purified to electrophoretic homogeneity using a variation of a three-step procedure developed previously for P450 3A4, with an overall yield of similar to 40%. Purified P450 3A5 was active in nifedipine oxidation, testosterone 6 beta-hydroxylation, aflatoxin 3 alpha-hydroxylation and 8,9-epoxidation, N-ethylmorphine N-demethylation, erythromycin N-demethylation, and d-benzphetamine N-demethylation. The reconstitution of nifedipine oxidation, testosterone 6 beta-hydroxylation, and the aflatoxin oxidation activities showed dependence upon the presence of cytochrome b(5), divalent cations, phospholipid mixtures, glutathione, and cholate similar to that previously found for purified P450 3A4. However, rates of the N-demethylations of N-ethylmorphine, erythromycin, and d-benzphetamine were as high or higher for P450 3A5 than P450 3A4 and were not particularly dependent upon modifications of reconstitution systems. (C) 1995 Academic Press, Inc.
引用
收藏
页码:374 / 384
页数:11
相关论文
共 64 条
  • [1] AOYAMA T, 1989, J BIOL CHEM, V264, P10388
  • [2] 5 OF 12 FORMS OF VACCINIA VIRUS-EXPRESSED HUMAN HEPATIC CYTOCHROME-P450 METABOLICALLY ACTIVATE AFLATOXIN-B1
    AOYAMA, T
    YAMANO, S
    GUZELIAN, PS
    GELBOIN, HV
    GONZALEZ, FJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) : 4790 - 4793
  • [3] EXPRESSION AND ENZYMATIC-ACTIVITY OF RECOMBINANT CYTOCHROME-P450 17-ALPHA-HYDROXYLASE IN ESCHERICHIA-COLI
    BARNES, HJ
    ARLOTTO, MP
    WATERMAN, MR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (13) : 5597 - 5601
  • [4] ISOLATION AND SEQUENCE DETERMINATION OF A CDNA CLONE RELATED TO HUMAN CYTOCHROME-P-450 NIFEDIPINE OXIDASE
    BEAUNE, PH
    UMBENHAUER, DR
    BORK, RW
    LLOYD, RS
    GUENGERICH, FP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) : 8064 - 8068
  • [5] BORK RW, 1989, J BIOL CHEM, V264, P910
  • [6] CATALYTIC ACTIVITIES OF HUMAN LIVER CYTOCHROME-P-450-IIIA4 EXPRESSED IN SACCHAROMYCES-CEREVISIAE
    BRIAN, WR
    SARI, MA
    IWASAKI, M
    SHIMADA, T
    KAMINSKY, LS
    GUENGERICH, FP
    [J]. BIOCHEMISTRY, 1990, 29 (51) : 11280 - 11292
  • [7] CZERWINSKI M, 1991, CANCER RES, V51, P4636
  • [8] DEBOER HA, 1986, MAXIMIZING GENE EXPR, P255
  • [9] HIGH-LEVEL EXPRESSION IN ESCHERICHIA-COLI OF ENZYMATICALLY ACTIVE FUSION PROTEINS CONTAINING THE DOMAINS OF MAMMALIAN CYTOCHROMES-P450 AND NADPH-P450 REDUCTASE FLAVOPROTEIN
    FISHER, CW
    SHET, MS
    CAUDLE, DL
    MARTINWIXTROM, CA
    ESTABROOK, RW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10817 - 10821
  • [10] HIGH-LEVEL EXPRESSION OF FUNCTIONAL HUMAN CYTOCHROME-P450 1A2 IN ESCHERICHIA-COLI
    FISHER, CW
    CAUDLE, DL
    MARTINWIXTROM, C
    QUATTROCHI, LC
    TUKEY, RH
    WATERMAN, MR
    ESTABROOK, RW
    [J]. FASEB JOURNAL, 1992, 6 (02) : 759 - 764